Glaxosmithkline Pharmaceuticals Ltd - Stock Price

As on7 Apr 2020
  • NSE : GLAXO
  • BSE : 500660
  • ISIN CODE : INE159A01016
  • Industry : Pharmaceuticals & Drugs
  • House : Glaxosmithkline - MNC
Glaxosmithkline Pharmaceuticals Ltd is not traded on BSE/NSE
1248.50
+1.98 %+24.3
Previous Close 1224.20
Day's Open 1260.00
Bid Price (Qty) 0.00 (0)
Offer Price (Qty) 1248.50 (69)
Day’s High - Low 1265.00 - 1175.00
52 Week Range 962.65 - 1748
Volume Traded (in 000's) 162.39
Value traded (in Cr.) 19.71
PE Ratio (x) 221.84
M Cap (in Cr.)21105.45

Glaxosmithkline Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 21105.45
Earning Per Share (EPS TTM) (Rs.) 5.62
Price To Earnings (P/E) Ratio 221.84
Book Value Per Share (Rs.) 100.59
Price/Book (MRQ) 12.39
Price/Earning (TTM) 124.95
ROCE (%) 31.45
PAT Margin 13.60
Dividend Yield 1.61
Face Value 10

Financial Summary

Parameter MAR 19 (`Mn.) MAR 18 (`Mn.) YoY %Change
Balance Sheet :
Share Capital1694.06847.03100.00
Total Non-Current Liabilities28603.6926324.748.66
Total Current Liabilities28040.6629489.80-4.91
Total Liabilities78042.6476387.822.17
Total Non-Current Assets44450.5541032.588.33
Currents Investments0.000.000.00
Cash and Bank11713.4612964.11-9.65
Total Current Assets33592.0935355.24-4.99
Total Assets78042.6476387.822.17
Profit & Loss :
Gross Sales31281.2028956.508.03
Net Sales31281.2028714.508.94
Total Expenditure25273.2023656.606.83
Operating Profit7031.205603.4025.48
Profit After Tax4453.903507.3026.99
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
ITI Multi-Cap Fund-Reg(G)1.65
ITI Long Term Equity Fund-Reg(G)0.74
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Peer Comparison

More Comparison »

Share Holdings

Description Percent of Share (%)
Promoters75
Non-Institution13.47
Fi/Banks/Insurance7.05
Mutual Funds/Uti3.97
FII0
Government0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: R S Karnad
  • Managing Director: A Vaidheesh
  • Secretary:

Registered Office

Address : Dr Annie Besant Road,Worli, Mumbai,
Maharashtra-400030 Tel : 022-24959595 Fax : 022-24959494 Email : askus@gsk.com Website : www.gsk-india.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. was incorporated in the year 1924. Its today's share price is 1245.85. Its current market capitalisation stands at Rs 21105.45 Cr. In the latest quarter, company has reported Gross Sales of Rs. 31281.19 Cr and Total Income of Rs.32304.36 Cr. The company's management includes S Williams, P Thakur, D Sundaram, A N Roy, R Krishnaswamy, N Kaviratne ( C B E ), PV Bhide, A Bansal, A Vaidheesh, R S Karnad.

It is listed on the BSE with a BSE Code of 500660 , NSE with an NSE Symbol of GLAXO and ISIN of INE159A01016. It's Registered office is at Dr Annie Besant Road,Worli,Mumbai-400030, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, Lovelock & Lewes, Price Waterhouse & Co, Price Waterhouse & Co Bangalore LLP

Latest News

close